Option Chain

Caredx Inc

CDNANASDAQ · USD

78.56USD+2.23 (+2.93%)

5710

Caredx Inc (CDNA) Option Chain

Caredx Inc trades at $78.56, up 2.93%, with an IV Rank of 22.62%. This is low versus the past year, and the company carries a market cap of $4,011M in the Diagnostics & Research industry. On the Nov 20, 2026 chain, the at the money $80.00 strike shows calls at $1.60 / $3.90 and puts at $4.40 / $6.90, both carrying about $3.48 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $80.00 calls, at 75 contracts, and the $90.00 puts, at 75, as of Nov 5, 2026.

Tracking the CDNA option chain helps you see every strike and expiry on Caredx Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CDNA options activity at a glance. Use our scanner to monitor the CDNA option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CDNA stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where CDNA options are being actively traded, and where they are not.

CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company also offers TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution; Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software.

CALLs									PUTs
Prob. OTM %	Open Interest	Volume	Extrinsic Value	Intrinsic Value	Bid	Ask	Strike	Moneyness %	Bid	Ask	Intrinsic Value	Extrinsic Value	Volume	Open Interest	Prob. OTM %
26.74	2,290	0	-0.36	8.56	6.40	10.00	70.00	-8.29	—	2.45	0.00	2.45	0	64	73.26
46.62	2,086	24	1.84	3.56	4.30	6.50	75.00	-1.74	2.55	4.70	0.00	3.63	1	7	53.38
66.15	506	75	2.75	0.00	1.60	3.90	80.00	+4.81	4.40	6.90	1.44	4.21	9	12	33.85
81.26	40	11	1.33	0.00	0.25	2.40	85.00	+11.36	9.10	11.10	6.44	3.66	2	36	18.74
90.84	39	7	0.98	0.00	0.50	1.45	90.00	+17.91	12.00	15.50	11.44	2.31	75	569	9.16

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

IndustryDiagnostics & Research
SectorHealthcare
IV Rank22.62% Low
Market cap (M$)4,011
52 weeks high-16.00%
52 weeks low423.53%
Analyst recommendationBuy
1.57
Target price$93.50
-16.84% below the current stock price
Dividend—
Payout ratio—
Earnings date2026-10-29
P/E31.88
Future P/E48.36
EPS (ttm)2.39
EPS growth next 5 years55.24%

As of Nov 5, 2026

Browse all Option Chain tickers